You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Biosynthetic Degradable Textile for Soft Tissue Reconstruction

    SBC: Deep Blue Medical Advances, Inc.            Topic: 300

    AbstractBiosynthetic or synthetic degradable hernia mesh is the fastest growing segment of the hernia mesh marketreaching$M in sales inwith Bard controllingof the US marketfollowed by GoreNovus Scientificand EthiconWhile biosynthetic mesh may be used in any type of hernia repairit is most commonly used in ventral hernia repair cases where there is an increased risk of bacterial infectionThe reason ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  2. Ablation of the pathogenic RNA transcript associated with myotonic dystrophy, DM1

    SBC: ENZERNA BIOSCIENCES LLC            Topic: NIAMS

    ABSTRACTMyotonic muscular dystrophyDMDis a genetic disorder characterized by muscle degeneration and weaknessIt is a common form of muscular dystrophy that generally begins in adulthoodUnfortunatelythere are no approved curative therapies for DMtreatments are largely palliativeThe more severe formmyotonic dystrophy typeDMis caused by theCTG n expansion in theUTR of the dystrophia myotonica protein ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  3. Accurate Ranging and Time Transfer (ARTT)

    SBC: SETTER RESEARCH INC            Topic: A19025

    The Global Positioning System (GPS) has revolutionized military operations by providing global access to high-quality position, navigation, and time (PNT) data. Along with the rise in GPS usage has been a parallel increase in threats to GPS data availability. GPS signals are easily jammed due to their low signal power and fixed frequency of operation. Spoofing attacks threaten military systems bei ...

    SBIR Phase I 2019 Department of DefenseArmy
  4. ACE Booster

    SBC: GLOYER-TAYLOR LABORATORIES INC            Topic: T1

    GTL has been developing a suite of transformational technologies that have the capability to disrupt the traditional launch vehicle paradigm.BHL composite cryotank technology provides a four times improvement over large aluminum iso-grid tanks, offering a 6 percentage point improvement in small stage PMF. Superior Stability Engine is an innovative liquid rocket engine configured to maximize combus ...

    STTR Phase II 2019 National Aeronautics and Space Administration
  5. Achievability Control Theory for Supervisory Computer-Human Systems

    SBC: Raven Research Corporation            Topic: N/A

    The objective of the proposed project is the development of technology for more efficient and effective human-computer supervision of complex systems. Systems that combine humans and automation in a synergistic or cooperative manner may be termed hybridsystems. Hybrid systems offer advantages over both purely automated systems and purely manual systems in many circumstances. However, future hybrid ...

    SBIR Phase I 2003 Department of DefenseArmy
  6. A Comprehensive Newborn Screening Solution for Duchenne and Congenital Muscular Dystrophies

    SBC: BAEBIES, INC.            Topic: NICHD

    Congenital genetic abnormalities are a leading cause of childhood mortality and morbidity. While routine newborn screening (NBS) has dramatically improved health outcomes, many congenital disorders such as Duchenne muscular dystrophy (DMD) and other congenital muscular dystrophies (CMD) are not currently detected by routine NBS. Presymptomatic identification through NBS is critical to facilitate e ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  7. ACROSS THE RURAL SOUTH.

    SBC: Forest Care Company            Topic: N/A

    MILLIONS OF ACRES OF UNMANAGED PRIVATE NON-INDUSTRIAL FORESTLAND ACROSS THE RURAL SOUTH PRESENT AN EXTRAORDINARY OPPOR- TUNITY TO CREATE NEW BUSINESSES AND JOBS. MOST PRESENT FORESTRY CONTRACTORS WHO PROVIDE SERVICES SUCH AS TIMBER HARVESTING AND SITE PREPARATION OPERATE WITH EQUIPMENT TOO LARGE AND INEFFICIENT FOR LANDOWNERS. TO ASSIST LANDOWNERS IN BEGINNING INTENSIVE MANAGEMENT, ADDITIONAL NEW ...

    SBIR Phase I 1983 Department of Agriculture
  8. ADAPTING EXISTING CURRICULA FOR PROMOTING SOCIAL AND ADA

    SBC: THREE C INSTITUTE FOR SOCIAL DEVELOPMT            Topic: N/A

    Location 1903 N HARRISON AVE, STE 101 CARY, NC 27513 United States N44MH0664102C $365 147.00 2 005 ADAPTING EXISTING CURRICULA FOR PROMOTING SOCIAL AND ADA Department of Health and Human Services National Institutes of Health SBIR PHS2006-1 THREE C INSTIT ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  9. Adding SpO2 and Hemoglobin Determinations to Non-Invasive Hemodynamic Monitoring for Healthy Independent Living

    SBC: RFPi, Inc.            Topic: NHLBI

    Abstract Technologies to safelyeffectivelyand efficiently monitor clinical cardiovascular status in patients with one or more cardiovascular related diseases are an unmet need in healthcareSince small changes in clinical status can compound rapidlymonitoring a number of physiologic status parametersPSPssimultaneously and trending their changes over time is crucial for early interventionin order to ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  10. Adipose Derived Adult Stem Cells in Hepatic Regeneration

    SBC: VESTA THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Liver failure secondary to hepatitis, hepatotoxin exposure, and cirrhosis threatens the lives of thousands in the United States alone. Estimates of yearly direct healthcare costs for liver disease in the U.S. range from $60 billion to over $100 billion. Vesta Therapeutics has developed proprietary technologies for the isolation and preservation of primary hepat ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government